{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:51:45Z","timestamp":1778892705680,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["21002411500"],"award-info":[{"award-number":["21002411500"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270772"],"award-info":[{"award-number":["82270772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970667"],"award-info":[{"award-number":["81970667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbadis.2025.167754","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:43:07Z","timestamp":1740987787000},"page":"167754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Both carvedilol and cimetidine alleviate cisplatin-induced nephrotoxicity via downregulating OCT2"],"prefix":"10.1016","volume":"1871","author":[{"given":"Huan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichun","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbadis.2025.167754_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2025.167754_bb0010","first-page":"206","article-title":"Cisplatin in cancer treatment","author":"Romani","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.bbadis.2025.167754_bb0015","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s40265-019-01182-1","article-title":"Prevention of cisplatin-induced acute kidney injury: a systematic review and meta-analysis","volume":"79","author":"Hamroun","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167754_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167754_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"10.1016\/j.bbadis.2025.167754_bb0030","first-page":"9(APR)","article-title":"Necrostatin-1 attenuates cisplatin-induced nephrotoxicity through suppression of apoptosis and oxidative stress and retains Klotho expression","author":"Ning","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbadis.2025.167754_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05104-0","article-title":"Histone methyltransferase MLL1 drives renal tubular cell apoptosis by p53-dependent repression of E-cadherin during cisplatin-induced acute kidney injury","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167754_bb0040","first-page":"1664","article-title":"MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167754_bb0045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.00009.2021","article-title":"Regulation of solute carriers oct2 and OAT1\/3 in the kidney: a phylogenetic, ontogenetic, and cell dynamic perspective","volume":"102","author":"Pou Casellas","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2025.167754_bb0050","series-title":"Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2","volume":"Vol 167","author":"Ciarimboli","year":"2005"},{"issue":"15","key":"10.1016\/j.bbadis.2025.167754_bb0055","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/1078-0432.CCR-14-0319","article-title":"Cisplatin-induced renal injury is independently mediated by OCT2 and p53","volume":"20","author":"Sprowl","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167754_bb0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167754_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10157-012-0638-y","article-title":"Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events","volume":"16","author":"Iwata","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167754_bb0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-012-1163-2","article-title":"The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule","volume":"464","author":"Jenkinson","year":"2012","journal-title":"Pflugers Arch."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167754_bb0075","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/10408440802368642","article-title":"A comparison of rat chronic progressive nephropathy with human renal disease-implications for human risk assessment","volume":"39","author":"Hard","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167754_bb0080","article-title":"Classical complement pathway inhibition in a \u201chuman-on-A-chip\u201d model of autoimmune demyelinating neuropathies","volume":"5","author":"Rumsey","year":"2022","journal-title":"Adv. Ther. (Weinh.)"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167754_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19293-3","article-title":"3D proximal tubule-on-chip model derived from kidney organoids with improved drug uptake","volume":"12","author":"Aceves","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167754_bb0090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.stemcr.2018.06.018","article-title":"A simple bioreactor-based method to generate kidney organoids from pluripotent stem cells","volume":"11","author":"Przepiorski","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167754_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167754_bb0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nprot.2012.015","article-title":"Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus","volume":"7","author":"Seki","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2025.167754_bb0105","first-page":"47(W1)","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2025.167754_bb0110","first-page":"357","article-title":"Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats","author":"Stanton","year":"2022","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167754_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2486-2","article-title":"Selective inhibition on organic cation transporters by carvedilol protects mice from cisplatin-induced nephrotoxicity","volume":"35","author":"Guo","year":"2018","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167754_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ki.2008.214","article-title":"Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells","volume":"74","author":"Periyasamy-Thandavan","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2025.167754_bb0125","first-page":"68","article-title":"CPSF6-mediated XBP1 3\u2019UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma","author":"Zhu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbadis.2025.167754_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/ajprenal.90545.2008","article-title":"The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity","volume":"296","author":"Pabla","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbadis.2025.167754_bb0135","first-page":"543","article-title":"Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.bbadis.2025.167754_bb0140","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1634\/theoncologist.2018-0037","article-title":"Pantoprazole, an inhibitor of the organic cation transporter 2, does not ameliorate cisplatin-related ototoxicity or nephrotoxicity in children and adolescents with newly diagnosed osteosarcoma treated with methotrexate, doxorubicin, and cisplatin","volume":"23","author":"Fox","year":"2018","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167754_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-003-0620-1","article-title":"Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial","volume":"52","author":"Santoso","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167754_bb0150","first-page":"321","article-title":"Augmented nephroprotective effect of liraglutide and rabeprazole via inhibition of OCT2 transporter in cisplatin-induced nephrotoxicity in rats","author":"Sharaf","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.167754_bb0155","first-page":"8","article-title":"The role of NF-kB in the downregulation of organic cation transporter 2 expression and renal cation secretion in kidney disease","author":"Han","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"issue":"16","key":"10.1016\/j.bbadis.2025.167754_bb0160","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1158\/1078-0432.CCR-10-0949","article-title":"Influence of Oct1\/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-\u03b2-D-glucosaminidase","volume":"16","author":"Franke","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167754_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/jpet.108.147918","article-title":"Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells","volume":"329","author":"Tsuda","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.bbadis.2025.167754_bb0170","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.fct.2012.03.077","article-title":"Ameliorative effects of SLC22A2 gene polymorphism 808 G\/T and cimetidine on cisplatin-induced nephrotoxicity in Chinese cancer patients","volume":"50","author":"Zhang","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167754_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00008390-200010010-00009","article-title":"Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study","volume":"10","author":"Schmidt","year":"2000","journal-title":"Melanoma Res."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167754_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167754_bb0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.taap.2016.10.022","article-title":"DNA damage response in nephrotoxic and ischemic kidney injury","volume":"313","author":"Yan","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167754_bb0190","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/BJ20141291","article-title":"Distinct lipid effects on tBid and Bim activation of membrane permeabilization by pro-apoptotic Bax","volume":"467","author":"Shamas-Din","year":"2015","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167754_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.kint.2022.08.022","article-title":"Phosphoglycerate mutase 5 initiates inflammation in acute kidney injury by triggering mitochondrial DNA release by dephosphorylating the pro-apoptotic protein Bax","volume":"103","author":"Li","year":"2023","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167754_bb0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","article-title":"Mechanisms of caspase activation and inhibition during apoptosis","volume":"9","author":"Shi","year":"2002","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167754_bb0205","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2013.489","article-title":"Klotho has dual protective effects on cisplatin-induced acute kidney injury","volume":"85","author":"Panesso","year":"2014","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167754_bb0210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/clpt.2013.145","article-title":"Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearance","volume":"94","author":"Sprowl","year":"2013","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:32:09Z","timestamp":1749558729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925000997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0925443925000997"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167754","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Both carvedilol and cimetidine alleviate cisplatin-induced nephrotoxicity via downregulating OCT2","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167754"}}